long intergenic non-protein coding RNA 910Genealiases: []
Q-omics provides the consensus-scored LINC00910 profile across patient tissues and cancer cell-line models. LINC00910 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, LINC00910 is differentially expressed in 12, with the highest sampling consensus in KICH. Additionally, LINC00910 RNA expression shows 18,679 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight MESO, KICH, and KIRP as cancer lineages where LINC00910 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00910 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00910 survival associations across molecular data types. LINC00910 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00910 RNA expression–survival associations across cancer types. High LINC00910 expression shows unfavorable associations in SKCM and COAD, but favorable associations in MESO, BRCA, READ and KIRC. The MESO Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for LINC00910 RNA expression.
This table summarizes LINC00910 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00910. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00910 shows lower tumor expression in KICH and THCA and higher tumor expression in LIHC, BLCA, CHOL and COAD. The KICH box plot shows higher LINC00910 RNA expression in normal versus tumor tissue (log2 FC = −0.949, t-test p < 0.001).
This table shows molecular features associated with LINC00910 in patient tissues and cancer cell lines. In patient samples, LINC00910 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
